Journal of Managed Care & Specialty Pharmacy

Scope & Guideline

Innovating Patient-Centered Solutions in Healthcare

Introduction

Delve into the academic richness of Journal of Managed Care & Specialty Pharmacy with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2376-0540
PublisherACAD MANAGED CARE PHARMACY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2014 to 2024
AbbreviationJ MANAG CARE SPEC PH / J. Manag. Care Spec. Pharm.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address100 N PITT ST, 400, ALEXANDRIA, VA 22314-3134

Aims and Scopes

The Journal of Managed Care & Specialty Pharmacy focuses on the intersection of managed care pharmacy, health economics, and specialty medication management. It aims to disseminate research that informs best practices in medication management, health care resource utilization, and cost-effectiveness in various therapeutic areas.
  1. Health Economics and Cost-Effectiveness Analysis:
    Research in this area examines the economic implications of pharmaceutical therapies, focusing on cost-effectiveness, budget impact, and health care resource utilization. It aims to provide evidence that supports decision-making in managed care and formulary management.
  2. Managed Care Pharmacy Practices:
    This focuses on the roles and impacts of pharmacists in managed care settings, including medication therapy management, adherence strategies, and the integration of pharmacists into healthcare teams to optimize patient outcomes.
  3. Specialty Pharmacy Management:
    The journal emphasizes research on the management of specialty medications, including their utilization patterns, adherence, and economic impact on health care systems.
  4. Health Disparities and Equity:
    Research addressing racial, ethnic, and socioeconomic disparities in medication access, utilization, and outcomes is a significant focus, with the aim of promoting equitable health care practices.
  5. Real-World Evidence and Outcomes:
    The journal publishes studies that utilize real-world data to assess the effectiveness and safety of medications in diverse populations, enhancing the understanding of treatment outcomes beyond clinical trials.
  6. Policy and Regulatory Implications:
    Research that explores the impact of health care policies, insurance coverage dynamics, and regulatory frameworks on medication access and cost management is central to the journal's scope.
The Journal of Managed Care & Specialty Pharmacy has shown a dynamic evolution in its research focus, with several themes emerging as particularly relevant in recent publications. These trends reflect ongoing changes in health care delivery, patient needs, and policy environments.
  1. Digital Health and Telehealth Solutions:
    There is an increasing emphasis on the evaluation of digital health technologies and telehealth interventions, particularly in the context of medication management and adherence, reflecting the shift towards remote care and digital solutions.
  2. Health Equity and Social Determinants of Health:
    Research addressing health disparities and the impact of social determinants of health on medication access and outcomes is on the rise, highlighting the need for equitable health care practices.
  3. Value-Based Care Models:
    Emerging studies focus on value-based care frameworks that assess the effectiveness and economic impact of treatments in relation to patient outcomes, aligning with broader health care reforms.
  4. Patient-Centered Outcomes and Experiences:
    There is a growing trend in research that prioritizes patient-reported outcomes and experiences, emphasizing the importance of incorporating patient perspectives in medication management and treatment evaluations.
  5. Integrated Care Approaches:
    Research that explores integrated care models, particularly in managing chronic diseases with multiple comorbidities, is gaining attention, reflecting an overarching shift towards holistic patient care.
  6. Biosimilars and Specialty Drug Management:
    The journal is seeing an increased focus on the evaluation and management of biosimilars within specialty pharmacy contexts, driven by the need for cost-effective alternatives to high-priced biologics.

Declining or Waning

While the Journal of Managed Care & Specialty Pharmacy has maintained a robust focus on several key areas, some themes have shown signs of declining prominence in recent publications. These waning topics may reflect shifts in research priorities or changes in the health care landscape.
  1. Traditional Pharmacoeconomics:
    Research focusing solely on traditional pharmacoeconomic evaluations without incorporating real-world evidence or patient-centered outcomes appears to be declining, as the field increasingly values comprehensive approaches that include patient perspectives.
  2. Generalized Drug Utilization Studies:
    Broad studies examining drug utilization trends without specific focus on therapeutic areas or patient populations are becoming less frequent, as more targeted investigations into specialty medications and specific disease states gain traction.
  3. Single-Disease Focus:
    Studies that address treatment patterns or economic outcomes exclusively within a single disease area are waning, as there is a growing trend towards integrated care models that consider comorbidities and multi-condition management.
  4. Historical Comparisons of Drug Prices:
    Research that solely compares historical drug prices without contextualizing these findings within current health care policies or economic frameworks is becoming less common, as discussions around drug pricing now emphasize value and outcomes.

Similar Journals

Journal of the American College of Clinical Pharmacy

Exploring innovative practices in pharmaceutical science.
Publisher: WILEYISSN: Frequency: 6 issues/year

Welcome to the Journal of the American College of Clinical Pharmacy, a distinguished publication in the field of pharmacy and related health professions, published by WILEY since 2018. With a strong commitment to advancing clinical pharmacy practices, this journal serves as a vital resource for researchers, professionals, and students seeking to stay at the forefront of pharmaceutical science. Boasting impressive category quartiles, including Q2 in Pharmaceutical Science and Pharmacy, alongside a notable Scopus ranking in Health Professions and Pharmacology, it stands as a key platform for disseminating cutting-edge research and innovative approaches in clinical pharmacy. Although this journal maintains a subscription-based model, its rigorous peer review process and emphasis on high-quality research ensure that it continues to make significant contributions to the field. Join us in exploring the latest insights and developments from a community dedicated to improving patient care and health outcomes.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Empowering health-system pharmacy with innovative insights.
Publisher: OXFORD UNIV PRESS INCISSN: 1079-2082Frequency: 24 issues/year

American Journal of Health-System Pharmacy, published by Oxford University Press Inc., stands as a vital resource in the domains of pharmacy and health policy. With an ISSN of 1079-2082 and E-ISSN 1535-2900, this esteemed journal provides a platform for disseminating high-quality research and insights that influence the practice of pharmacy and health management. The journal boasts a Q1 ranking in Pharmacy and ranks within the top quartiles in Health Policy and Medicine, reflecting its substantial impact on the field. With a comprehensive focus extending from 1995 to 2024, it caters to a diverse audience, including health professionals, researchers, and students interested in the ever-evolving dynamics of health-system pharmacy. Although it does not offer Open Access, the journal ensures that subscribers gain access to cutting-edge research essential for advancing health implications in pharmacy practice. By prioritizing innovative studies and reviews, the American Journal of Health-System Pharmacy plays a crucial role in shaping effective pharmaceutical care strategies and policies.

Research in Social & Administrative Pharmacy

Empowering researchers to drive change in pharmaceutical sciences.
Publisher: ELSEVIER SCIENCE INCISSN: 1551-7411Frequency: 12 issues/year

Research in Social & Administrative Pharmacy, published by Elsevier Science Inc, is a premier academic journal that plays a pivotal role in shaping the field of pharmaceutical sciences and pharmacy practice. With an impressive impact factor and ranked in the Q1 category for both Pharmaceutical Science and Pharmacy, this journal is dedicated to the dissemination of cutting-edge research from 2005 to 2024. Targeting a diverse audience of researchers, professionals, and students, the journal covers a broad spectrum of topics including social pharmacy, policy, and administrative aspects of pharmacy practice, contributing to advancements in healthcare. As an essential resource for those engaging in pharmaceutical research, the journal upholds rigorous peer-review standards and ensures wide accessibility to influential studies that address contemporary issues in pharmacy and healthcare administration, making it an invaluable tool for knowledge enhancement and practical applications.

International Journal of Clinical Pharmacy

Enhancing Therapeutic Outcomes with Cutting-Edge Insights
Publisher: SPRINGERISSN: 2210-7703Frequency: 6 issues/year

The International Journal of Clinical Pharmacy, published by Springer, serves as a pivotal platform for advancing research in the fields of Pharmaceutical Science and Pharmacology. This esteemed journal, recognized for its significant impact with an impressive Q1 ranking in Pharmacy and multiple Q2 designations, provides a dedicated space for scholars and practitioners to share innovative findings and methodologies that enhance clinical pharmacy practices. With an international reach and publication spanning from 2011 to 2024, the journal aims to facilitate knowledge exchange among researchers, professionals, and students, ultimately contributing to improved therapeutic outcomes. As an open-access journal, it promotes widespread dissemination of vital research, ensuring that cutting-edge clinical pharmacy knowledge is accessible to all stakeholders in the healthcare continuum.

Journal of Pharmaceutical Health Care and Sciences

Exploring the nexus of pharmacy and healthcare excellence.
Publisher: BMCISSN: 2055-0294Frequency: 1 issue/year

The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.

European Journal of Hospital Pharmacy

Innovating Healthcare Through Hospital Pharmacy Research
Publisher: BMJ PUBLISHING GROUPISSN: 2047-9956Frequency: 6 issues/year

The European Journal of Hospital Pharmacy, published by the prestigious BMJ PUBLISHING GROUP, stands as a vital resource in the field of pharmacy, specifically focused on practices within hospital settings. With its ISSN 2047-9956 and E-ISSN 2047-9964, this journal provides an essential platform for researchers, practitioners, and students to disseminate and access high-quality research that influences clinical practice. Recognized for its significant impact, the journal has achieved a commendable Q2 ranking in both the Pharmacology, Toxicology and Pharmaceutics (miscellaneous) and Pharmacy categories according to Scopus, highlighting its status within the academic community. The journal is indexed among the top 18% in its category, showcasing innovative research and advancements in the field. While the European Journal of Hospital Pharmacy does not operate under an open-access model, its deep commitment to enhancing pharmaceutical care within European hospital settings remains undeterred. The journal also covers a converged period from 2010 to 2024, providing comprehensive insights into evolving practices and challenges. As a premier publication, it plays an essential role in education and professional development, making it indispensable for those involved in pharmacy and healthcare.

American Health and Drug Benefits

Pioneering insights into health policy and drug accessibility.
Publisher: ENGAGE HEALTHCARE COMMUNICATIONS INCISSN: 1942-2962Frequency: 9 issues/year

American Health and Drug Benefits, published by ENGAGE HEALTHCARE COMMUNICATIONS INC, is a pivotal journal dedicated to advancing the understanding of health policy and management in the pharmaceutical sector. Launched in 2009, this journal serves as a vital resource for researchers, practitioners, and policymakers engaged in the dynamic interplay between health care quality, drug accessibility, and effective management strategies. With its ISSN 1942-2962 and E-ISSN 1942-2970, the journal has established itself within the community, evidenced by its 2023 Scopus rankings, including Q4 in Health Policy and Q3 in Strategy and Management. Although currently lacking an open-access model, American Health and Drug Benefits remains a crucial platform for disseminating high-quality research that informs health care delivery and policy decisions in the United States. Its commitment to rigorous scholarship contributes to better health outcomes and fosters innovation in drug benefits management.

Journal of Pharmacy and Bioallied Sciences

Unlocking Potential in Allied Health Research
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0976-4879Frequency: 6 issues/year

The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

Farmaceuticos Comunitarios

Elevating healthcare outcomes through shared knowledge.
Publisher: SOC ESPANOLA FARMACIA FAMILIAR & COMUNITARIA-SEFACISSN: 1885-8619Frequency: 4 issues/year

Farmaceuticos Comunitarios, an esteemed open-access journal published by the SOC ESPANOLA FARMACIA FAMILIAR & COMUNITARIA-SEFAC, focuses on advancing the field of community pharmacy and pharmaceutical care. With its inception in 2014 as an open-access journal, it aims to disseminate crucial research findings, case studies, and reviews that contribute to enhancing pharmaceutical services in the community. Based in Madrid, Spain, this journal serves as a platform for researchers, practitioners, and students to explore current trends and best practices within the sphere of pharmacy. Although it currently holds respectable rankings within Scopus, including its position in nursing and pharmacy disciplines, the journal continuously aspires to elevate its impact and relevance in the domain of pharmaceutical sciences. By providing unfettered access to quality research, Farmaceuticos Comunitarios plays a pivotal role in promoting knowledge sharing and improving healthcare outcomes within the community pharmacy sector.

Journal of Pharmaceutical Health Services Research

Shaping the future of health services through rigorous research.
Publisher: OXFORD UNIV PRESSISSN: 1759-8885Frequency: 4 issues/year

Journal of Pharmaceutical Health Services Research, published by Oxford University Press, stands as a vital resource within the fields of pharmacology, toxicology, and health economics. With a focus on the integration of pharmaceutical science and healthcare services, this journal addresses the rapidly evolving challenges faced by researchers and practitioners alike, promoting innovative solutions that can enhance patient care and improve health outcomes. Its Q3 ranking in key categories such as Economics and Pharmacology further highlights its significance in the academic landscape. Although not an open-access journal, the Journal of Pharmaceutical Health Services Research provides a platform for high-quality research and comprehensive reviews, making it an essential reference for those dedicated to advancing knowledge and practice in pharmaceutical health services. With converged years from 2010 to 2024, the journal continues to contribute valuable insights that foster collaboration among academics, industry professionals, and policymakers, reinforcing its role as a cornerstone of pharmaceutical research and health service innovation.